Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pivot Pharmaceuticals Inc 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 CAN

P: 604-805-7783

Description:

Pivot Pharmaceuticals, Inc. is a biopharmaceutical company which is engaged in the development of novel therapies to address unmet medical needs in women's health including oncology and urology. The Company's product pipeline includes P-001 for the treatment of dysmenorrhea, lower urinary tract symptoms, and kidney stones; P-002 to treat peri-menopausal hot flushes and P-003 for the prevention and treatment of migraine headaches and the progression from mild cognitive impairment to dementia which are in pre clinical trial stage. Pivot Pharmaceuticals, Inc. is based in Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 31,838
Shares Outstanding, K 88,440
Annual Sales, $ 0 K
Annual Net Income, $ -120 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,620 K
% of Insider Shareholders 35.98%
% of Institutional Shareholders 0.00%

Growth:

1-Year Total Return 365.19%
3-Year Total Return 260.00%
5-Year Total Return 200.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 07/10/18
Earnings Per Share ttm -0.02
Annual Dividend Rate, $ 0.00
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 04/21/15

PVOTF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 0.00
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -226.55
Return-on-Assets (Before Tax) -80.16
Net Margin % N/A
Debt/Equity -5.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.05
Interest Coverage -3.00
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar